{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:44:18Z","timestamp":1792586658041,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":172,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014688","name":"Region Uppsala","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005423","name":"Akademiska Sjukhuset","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurophysiology Practice"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.cnp.2026.06.010","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T23:40:57Z","timestamp":1782171657000},"page":"503-511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Long-term neuromuscular alterations during botulinum toxin treatment for chronic migraine"],"prefix":"10.1016","volume":"11","author":[{"given":"Tina","family":"Plens\u00e4ll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarika","family":"Liik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artor","family":"Pogosean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Garrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Olszowy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Jackmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Rostedt","family":"Punga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cnp.2026.06.010_bb0005","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1177\/0333102410364676","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial","volume":"30","author":"Aurora","year":"2010","journal-title":"Cephalalgia"},{"key":"10.1016\/j.cnp.2026.06.010_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108668","article-title":"Neurobiological mechanisms of botulinum neurotoxin-induced analgesia for neuropathic pain","volume":"259","author":"Bagues","year":"2024","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.cnp.2026.06.010_bb0015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s10194-018-0921-8","article-title":"Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation","volume":"19","author":"Bendtsen","year":"2018","journal-title":"J. Headache Pain."},{"key":"10.1016\/j.cnp.2026.06.010_bb0020","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1067\/mhn.2000.110960","article-title":"Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study","volume":"123","author":"Binder","year":"2000","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.cnp.2026.06.010_bb0025","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/365160a0","article-title":"Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25","volume":"365","author":"Blasi","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.cnp.2026.06.010_bb0030","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/head.13849","article-title":"Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative Review","volume":"60","author":"Burstein","year":"2020","journal-title":"Headache"},{"key":"10.1016\/j.cnp.2026.06.010_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103897","article-title":"Abnormal control of orbicularis oculi reflex excitability in multiple sclerosis","volume":"9","author":"Cabib","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cnp.2026.06.010_bb0040","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1177\/0333102410364677","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial","volume":"30","author":"Diener","year":"2010","journal-title":"Cephalalgia"},{"key":"10.1016\/j.cnp.2026.06.010_bb0045","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1526-4610.2010.01678.x","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program","volume":"50","author":"Dodick","year":"2010","journal-title":"Headache"},{"key":"10.1016\/j.cnp.2026.06.010_bb0050","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.jbiomech.2015.05.018","article-title":"A clinically relevant BTX-A injection protocol leads to persistent weakness, contractile material loss, and an altered mRNA expression phenotype in rabbit quadriceps muscles","volume":"48","author":"Fortuna","year":"2015","journal-title":"J. Biomech."},{"key":"10.1016\/j.cnp.2026.06.010_bb0055","doi-asserted-by":"crossref","first-page":"563","DOI":"10.55730\/1300-0144.5823","article-title":"Changes in blink reflex after simultaneous supraorbital and mental nerve stimulations in healthy subjects","volume":"54","author":"Gunduz","year":"2024","journal-title":"Turk J. Med. Sci."},{"key":"10.1016\/j.cnp.2026.06.010_bb0060","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1600-0404.1995.tb00449.x","article-title":"Blink reflex with stimulation of the mental nerve. Methodology, reference values, and some clinical vignettes","volume":"91","author":"Jaaskelainen","year":"1995","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.cnp.2026.06.010_bb0065","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3389\/fbioe.2020.00738","article-title":"Long-Term Effects With Potential Clinical Importance of Botulinum Toxin Type-A on Mechanics of Muscles Exposed","volume":"8","author":"Kaya","year":"2020","journal-title":"Front. Bioeng Biotechnol."},{"key":"10.1016\/j.cnp.2026.06.010_bb0070","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/dsu.12125","article-title":"Muscle atrophy beyond the clinical effect after a single dose of OnabotulinumtoxinA injected in the procerus muscle: a study with magnetic resonance imaging","volume":"39","author":"Koerte","year":"2013","journal-title":"Dermatologic Surg."},{"key":"10.1016\/j.cnp.2026.06.010_bb0075","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1007\/s10072-024-07947-1","article-title":"Botulinum toxin modulates the blink reflex via the trigeminal afferent system in hemifacial spasm: an early and late-term effect","volume":"46","author":"Kurtkaya Kocak","year":"2025","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.cnp.2026.06.010_bb0080","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00415-025-13246-2","article-title":"Longitudinal evaluation of serum neurofilament light levels in normal healthy volunteers: defining a threshold of concern","volume":"272","author":"Lanz","year":"2025","journal-title":"J. Neurol."},{"key":"10.1016\/j.cnp.2026.06.010_bb0085","article-title":"Botulinum neurotoxins: history, mechanism, and applications","volume":"169","author":"Monash","year":"2025","journal-title":"A Narrative Review. J. Neurochem."},{"key":"10.1016\/j.cnp.2026.06.010_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176279","article-title":"Botulinum toxin type a antinociceptive activity in trigeminal regions involves central transcytosis","volume":"963","author":"Nemanic","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cnp.2026.06.010_bb0095","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cnp.2020.01.002","article-title":"Botulinum toxin injections associated with suspected myasthenia gravis: an underappreciated cause of MG-like clinical presentation","volume":"5","author":"Punga","year":"2020","journal-title":"Clin. Neurophysiol. Pract."},{"key":"10.1016\/j.cnp.2026.06.010_bb0100","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.expneurol.2011.04.018","article-title":"Muscle-selective synaptic disassembly and reorganization in MuSK antibody positive MG mice","volume":"230","author":"Punga","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.cnp.2026.06.010_bb0105","doi-asserted-by":"crossref","first-page":"948","DOI":"10.2340\/00015555-2093","article-title":"Regional diffusion of botulinum toxin in facial muscles: a randomised double-blind study and a consideration for clinical studies with split-face design","volume":"95","author":"Punga","year":"2015","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.cnp.2026.06.010_bb0110","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/DSS.0000000000000805","article-title":"A randomized, comparative study to evaluate efficacy and safety of two injection volumes of abobotulinumtoxinA in treatment of glabellar lines","volume":"42","author":"Punga","year":"2016","journal-title":"Dermatologic Surg."},{"key":"10.1016\/j.cnp.2026.06.010_bb0115","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cnp.2023.05.005","article-title":"Keeping up appearances: don't frown upon the effects of botulinum toxin injections in facial muscles","volume":"8","author":"Punga","year":"2023","journal-title":"Clin. Neurophysiol. Pract."},{"key":"10.1016\/j.cnp.2026.06.010_bb0120","doi-asserted-by":"crossref","first-page":"15650","DOI":"10.1523\/JNEUROSCI.2618-11.2011","article-title":"Evidence for anterograde transport and transcytosis of botulinum neurotoxin A (BoNT\/A)","volume":"31","author":"Restani","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cnp.2026.06.010_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/toxins15010076","article-title":"Effects of botulinum toxin type A on the nociceptive and lemniscal somatosensory systems in chronic migraine: an electrophysiological study","volume":"15","author":"Sebastianelli","year":"2023","journal-title":"Toxins (Basel)."},{"key":"10.1016\/j.cnp.2026.06.010_bb0130","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1007\/s00266-020-01983-w","article-title":"A review of complications due to the use of botulinum toxin A for cosmetic indications","volume":"45","author":"Sethi","year":"2021","journal-title":"Aesth. Plast. Surg."},{"key":"10.1016\/j.cnp.2026.06.010_bb0135","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/WNP.0000000000000561","article-title":"Spontaneous, voluntary, and reflex blinking in clinical practice","volume":"36","author":"Valls-Sole","year":"2019","journal-title":"J. Clin. Neurophysiol."},{"key":"10.1016\/j.cnp.2026.06.010_bb0140","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1590\/S0004-282X2008000400012","article-title":"Beneficial effects of botulinum toxin type A in trigeminal neuralgia","volume":"66","author":"Zuniga","year":"2008","journal-title":"Arq. Neuropsiquiatr."}],"container-title":["Clinical Neurophysiology Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2467981X26000545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2467981X26000545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:10:37Z","timestamp":1792584637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2467981X26000545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":28,"alternative-id":["S2467981X26000545"],"URL":"https:\/\/doi.org\/10.1016\/j.cnp.2026.06.010","relation":{},"ISSN":["2467-981X"],"issn-type":[{"value":"2467-981X","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term neuromuscular alterations during botulinum toxin treatment for chronic migraine","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurophysiology Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cnp.2026.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of International Federation of Clinical Neurophysiology.","name":"copyright","label":"Copyright"}]}}